An embodiment provides a method for measuring zinc and copper in an aqueous sample, including: reducing an aqueous sample containing an amount of zinc and an amount of copper with a reducing agent; buffering the reduced aqueous sample; chelating the amount of copper in the buffered aqueous sample with a copper(I) chelating agent; measuring the amount of copper in the aqueous sample by measuring a first change in intensity of the absorbance of the copper chelated aqueous sample; chelating the amount of zinc in the buffered aqueous sample with a zinc(II) chelating agent; and measuring the amount of zinc in the aqueous sample by measuring a second change in intensity of the absorbance of the zinc chelated aqueous sample. Other aspects are described and claimed.

Analyte testing devices, assemblies, methods, operations, and systems are shown and described. In one embodiment, an apparatus to generate a test result from an assay when contacted with a sample includes a non-planar optics module to align the assay in an offset testing position. A modular interface assembly may support a motherboard and at least one non-planar optics module.

The invention is in the field of coagulation diagnostics and relates to a method for detecting lupus anticoagulant.

The invention provides an in vitro method for the determination of sun protection factor (SPF), in order to gain reproducibility and accuracy and replace the use of tests on living beings. Natural substrates of the human skin, like hyaluronic acid are tested in the form of solutions or in the form of a solid film in a modified spectrophotometer, at concentrations below 1% w/v. Once calibrated, the method is used to corroborate the protection factor offered by commercial sunscreens.

A method for detecting target biological species in a biological sample, the method being implemented in a device that makes it possible to concatenate the preparation of a sample for a detection via selective capture and a detection via biomolecular amplification.

An optical sensor has a substrate with first and second sides, one side being provided with first and second waveguides. The first and second waveguides have respective first and second measuring points along their respective lengths, each measuring point includes at least one interruption. The first measuring point, which belongs to the first waveguide, is functionalized by at least one coating while the second measuring point, which belongs to the second waveguide, is not functionalized by that same coating. The functionalized coating may include a substance (e.g., antibody) which corresponds to a pathogenic germ. A light source may simultaneously direct light into both waveguides and a light detector may simultaneously detect light signals exiting the waveguides. Differences in light intensities of the received light signals at one or more wavelengths, may reveal the presence of a pathogenic germ in a liquid sample applied to the first and second measurement points.

An embodiment provides a method for measuring zinc and copper in an aqueous sample, including: reducing an aqueous sample containing an amount of zinc and an amount of copper with a reducing agent; buffering the reduced aqueous sample; chelating the amount of copper in the buffered aqueous sample with a copper(I) chelating agent; measuring the amount of copper in the aqueous sample by measuring a first change in intensity of the absorbance of the copper chelated aqueous sample; chelating the amount of zinc in the buffered aqueous sample with a zinc(II) chelating agent; and measuring the amount of zinc in the aqueous sample by measuring a second change in intensity of the absorbance of the zinc chelated aqueous sample. Other aspects are described and claimed.

A blood analysis method includes: acquiring optical information which changes over time from a mixed liquid of a blood sample and a reagent for coagulation time measurement after mixing the blood sample and the reagent, and acquiring information related to a coagulation time and information related to a number of platelets in the blood sample based on the acquired optical information.

Systems and indicators for determining the presence or absence of specific environmental, exposure, or biological conditions are provided. Indicators include a plurality of sensors, each sensor independently having a biological or chemical sensing modality to detect one or more analytes of interest. Analytes of interest include nucleic acids (e.g., DNA, RNA, etc.), proteins, peptides, and other amino acid chains and may come from a subject or the microbiome of a subject. The signals from the plurality of sensors may be processed to provide a readily understandable readout concerning a health condition or predisposition of a subject, such as cancer and exposure to coronavirus. The signals from the plurality of sensors may be colorimetric (e.g. a color change in response to the presence or absence of an analyte), and a plurality of colorimetric signals may be combined to provide a readily understandable colorimetric output. Indicators may be wearable.

The invention relates to a testing system and related methods for detecting peritonitis or infection in peritoneal dialysate removed from a patient. The testing system can include a fluid sensor apparatus in a fluid line of a peritoneal dialysis cycler through which spent peritoneal dialysate can be pumped. The fluid sensor apparatus can detect one or more markers associated with peritonitis or infection.